← Back to Search

Testing Navigation Intervention (TNI). for Coronavirus

N/A
Waitlist Available
Led By Maria E Fernandez, PhD
Research Sponsored by The University of Texas Health Science Center, Houston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months after the intervention
Awards & highlights

Study Summary

This trial will assess how to best increase COVID-19 testing among vulnerable populations, and if interventions designed for low health literacy can help.

Eligible Conditions
  • Coronavirus
  • COVID-19

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~between baseline and 2 months after the intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and between baseline and 2 months after the intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Upper arm
Secondary outcome measures
Number of participants who appropriately used antigen test as assessed by survey
Number of participants who share antigen tests with close contacts who need to test as assessed by survey
Number of participants with a positive test who took mitigation measures as assessed by survey

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Testing Navigation Intervention (TNI).Experimental Treatment1 Intervention
Participants in the TNI arm will receive COVID-19 testing education and be navigated to PCR testing sites. Participants will also receive pre and post surveys.
Group II: Facilitated Self-Sampling Intervention (FSSI)Experimental Treatment1 Intervention
Participants in the FSSI arm will receive education on COVID-19 testing and be provided with rapid antigen tests. Participants will also receive pre and post surveys.
Group III: ControlActive Control1 Intervention
Participants in the Control Group arm will receive a CDC-designed COVID-19 testing brochures, and pre and post surveys only.

Find a Location

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
903 Previous Clinical Trials
319,697 Total Patients Enrolled
National Center for Advancing Translational Sciences (NCATS)NIH
320 Previous Clinical Trials
400,450 Total Patients Enrolled
Maria E Fernandez, PhDPrincipal InvestigatorThe University of Texas Health Science Center, Houston
3 Previous Clinical Trials
4,062 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment still available for this research project?

"According to the clinicaltrials.gov registry, this study is no longer recruiting patients having been posted initially on November 21st 2022 and last modified on the 3rd of that same month. Despite this trial's conclusion, 1032 other trials are currently open for enrolment at present."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Examining How a Facilitated Self-Sampling Intervention and Testing Navigation Intervention Influences COVID-19 Testing
Maria E Fernandez 2022. "Examining How a Facilitated Self-Sampling Intervention and Testing Navigation Intervention Influences COVID-19 Testing". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05606016.
~530 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top